ARTMX | JDMRX | ARTMX / JDMRX | |
Total Expense Ratio | 1.19 | 1.42 | 84% |
Annual Report Gross Expense Ratio | 1.19 | 1.42 | 84% |
Fund Existence | 28 years | 16 years | - |
Gain YTD | 14.543 | 5.551 | 262% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000 | 2500 | 40% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 3.69B | 23.4B | 16% |
Annual Yield % from dividends | 0.00 | 0.56 | - |
Returns for 1 year | 11.01 | 2.26 | 486% |
Returns for 3 years | 26.84 | 10.18 | 264% |
Returns for 5 years | -14.76 | -1.95 | 758% |
Returns for 10 years | -16.60 | 53.71 | -31% |
1 Day | |||
---|---|---|---|
ETFs / NAME | Price $ | Chg $ | Chg % |
IDNA | 23.00 | 0.43 | +1.91% |
iShares Genomics Immnlgy & Hlthcr ETF | |||
LFSC | 28.94 | 0.41 | +1.44% |
F/m Emerald Life Sciences Innovation ETF | |||
PIZ | 46.31 | 0.33 | +0.72% |
Invesco DW Developed Markets Momt ETF | |||
CGCB | 26.61 | 0.10 | +0.38% |
Capital Group Core Bond ETF | |||
QRMI | 15.79 | 0.01 | +0.10% |
Global X NASDAQ 100® Risk Mngd Inc ETF |